OSCR Stock Risk & Deep Value Analysis

Oscar Health Inc

Healthcare • Healthcare Plans

DVR Score

8.8

out of 10

Hidden Gem

What You Need to Know About OSCR Stock

We analyzed Oscar Health Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran OSCR through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated Mar 9, 2026Run Fresh Analysis →

How Risky Is OSCR Stock?

Overall Risk

Moderate

Financial Risk

Medium

Market Risk

Medium

Competitive Risk

Medium

Execution Risk

Medium

Regulatory Risk

High

What Are the Red Flags for OSCR?

  • Worse-than-expected Q1 2026 financial results or guidance

  • Increased regulatory scrutiny on insurtech models

  • Competitive pressures from established payers or other insurtechs

Unlock OSCR Red Flags & Risk Warnings

Create a free account to see the full analysis

What Does Oscar Health Inc (OSCR) Do?

Market Cap

$4.30B

Sector

Healthcare

Industry

Healthcare Plans

Employees

2,400

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Visit Oscar Health Inc Website

Is OSCR Stock Undervalued?

Oscar Health Inc. maintains a strong investment thesis, driven by the expanding adoption of its Oscar+ technology platform and a clear path towards sustained Adjusted EBITDA profitability. The company's unique tech-driven approach to healthcare insurance positions it for significant market share gains and future leadership in the evolving insurtech landscape. While the healthcare sector remains competitive and regulatory risks persist, Oscar's strategic partnerships and consistent execution of its scalable business model validate its potential for substantial, multi-bagger growth. The previous positive outlook is reinforced as no material changes have occurred since the last analysis, cementing its high-conviction status for long-term investors aiming for 10x potential.

Unlock the full AI analysis for OSCR

Get the complete DVR score, risk analysis, and more

Does OSCR Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Switching CostsIntangible Assets/IPNetwork Effects (through Oscar+ platform partners)

Oscar's moat is growing as its Oscar+ platform integrates deeper into provider systems and attracts more partners, increasing switching costs for both members and clients. Its data advantage and iterative product development create a virtuous cycle that will be difficult for legacy players to replicate quickly.

Moat Erosion Risks

  • Lack of scale compared to incumbent giants hindering cost advantages
  • Failure to secure significant new Oscar+ partnerships
  • Regulatory changes that limit data usage or platform flexibility

OSCR Competitive Moat Analysis

Sign up to see competitive advantages

What Could Drive OSCR Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings Report (Estimated mid-May 2026)
  • New Oscar+ platform partnership announcements
  • Continued positive Adjusted EBITDA guidance

Medium-Term (6-18 months)

  • Expansion into new state markets or employer groups
  • Further operational efficiency improvements driving margin expansion
  • Strategic acquisitions or deeper technology integrations

Long-Term (18+ months)

  • Establishment as a dominant tech-enabled healthcare platform beyond just insurance
  • Significant market share capture in the employer-sponsored health plan segment
  • Disruption of legacy insurer models through superior member engagement and cost efficiency

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for OSCR?

  • Consistent improvement in InsuranceCo Adjusted EBITDA and overall profitability

  • Acceleration in Oscar+ platform client acquisition and revenue growth

  • Significant expansion into new geographies or market segments

Bull Case Analysis

See what could go right with Premium

Compare OSCR to Similar Stocks

See how Oscar Health Inc stacks up against related companies in our head-to-head analysis.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for OSCR (Oscar Health Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More
Navigated to OSCR Stock Risk & Deep Value Analysis